Martin Shkreli, 10% Owner at KALOBIOS PHARMACEUTICALS INC (KBIO), sold 1,913,206 shares at $3.10 ($5.9M) on 2016-08-25, disclosed to the SEC on 2016-08-29.
Open-market sale of $5.9M KBIO by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| Filing → |
| KBIO | BUY | 2015-11-24 | $191K | — | Filing → |
| KBIO | BUY | 2015-11-23 | $94K | — | Filing → |
| KBIO | BUY | 2015-11-19 | $889K | — | Filing → |